Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
CGON
Stock Latest News
The Fly
CG Oncology price target raised to $56 from $52 at Morgan Stanley
11d ago
CGON
Premium
Company Announcements
CG Oncology Holds 2025 Annual Stockholders Meeting
21d ago
8K
CGON
Premium
Ratings
Promising Market Position and Investment Opportunity: CG Oncology’s Creto in NMIBC Treatment
26d ago
CGON
Premium
Company Announcements
CG Oncology Advances Bladder Cancer Therapies in Q1 2025
1M ago
CGON
Premium
Ratings
Promising Outlook for CG Oncology: Strong Financial Health and Positive Trial Results for Cretostimogene
2M ago
CGON
Premium
Ratings
CG Oncology, Inc.: Promising Outlook with Strong Clinical Performance and Strategic BLA Submission
2M ago
CGON
Premium
Ratings
Promising Prospects for CG Oncology’s Cretostimogene in NMIBC Treatment: Superior Efficacy and Strategic Expansion
2M ago
CGON
Premium
The Fly
CG Oncology reports Q1 EPS (45c), consensus (37c)
2M ago
CGON
Premium
The Fly
Apple downgraded, Reddit upgraded: Wall Street’s top analyst calls
2M ago
AZO
BDX
Premium
The Fly
CG Oncology initiated with an Overweight at JPMorgan
2M ago
CGON
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
NVS
BCDA
Premium
Ratings
Buy Rating for CG Oncology, Inc. Driven by Cretostimogene’s Potential in Bladder Cancer Treatment Amid BCG Shortage
2M ago
CGON
Premium
Market News
CG Oncology Stock (CGON) Surges 25% As Cancer Drug Shows Remarkable Results
2M ago
CGON
Premium
Company Announcements
CG Oncology Announces Promising Phase 3 Trial Results
2M ago
8K
CGON
Premium
Ratings
Promising Potential of CG Oncology’s Cretostimogene: A Buy Rating Justified by Superior Performance and Safety Profile
2M ago
CGON
Premium
Ratings
Buy Rating for CG Oncology, Inc. Driven by Promising Therapeutic Developments and Strong Safety Profile of Creto
2M ago
CGON
Premium
Ratings
Buy Rating for CG Oncology, Inc.: Promising Efficacy and Competitive Positioning in NMIBC Treatment
2M ago
CGON
Premium
The Fly
CG Oncology to hold a conference call
2M ago
CGON
Premium
The Fly
CG Oncology announces Phase 3 BOND-003 data presented at AUA meeting
2M ago
CGON
Premium
Ratings
CG Oncology’s Promising Phase 3 Data and Market Potential Justify Buy Rating
2M ago
CGON
Premium
The Fly
CG Oncology initiated with a Sector Perform at Scotiabank
2M ago
CGON
Premium
Ratings
Buy Rating Affirmed for CG Oncology Amid Promising Trial Data and Market Opportunities
3M ago
CGON
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
